Model Code: SCF-MOGN-ST-EPI-GMS-0001
Classification: Systems Biology + Multi-Omics Threshold Dynamics Modeling Framework
I. SCOPE & OBJECTIVE
To construct a quantitative, multi-omic gene-network model that defines:
- The biological seizure threshold (ST) as a dynamic systems variable
- The transition from subthreshold → ictal state
- The multi-layer gene-network interactions driving threshold collapse
Goal:
Enable predictive, personalized, and intervention-guided control of seizure onset.
II. SCF SEIZURE THRESHOLD (ST) — SYSTEM DEFINITION
Conceptual Definition
The seizure threshold is a network equilibrium state governed by:
- Excitatory vs inhibitory gene activity
- Neuroimmune load
- Bioenergetic capacity
- Network synchronization
SCF Threshold Equation (Systems Model)
Variable | Meaning |
Inhibitory gene network activity (GABAergic) | |
Bioenergetic capacity | |
Network resilience | |
Excitatory gene activity | |
Inflammatory signaling | |
Network synchronization pressure |
III. CORE GENE NETWORK MODULES
3.1 Excitatory Network (Pro-Seizure Module)
Gene Cluster | Function |
GRIN1, GRIN2B | NMDA receptor signaling |
GRIA1 | AMPA receptor activation |
SCN8A, SCN2A | Sodium channel excitability |
Output: ↑ Depolarization, ↓ threshold
3.2 Inhibitory Network (Protective Module)
Gene Cluster | Function |
GABRA1, GABRB3 | GABA-A receptor |
GAD1, GAD2 | GABA synthesis |
SLC6A1 | GABA transport |
Output: ↑ Threshold stabilization
3.3 Neuroimmune Network
Gene Cluster | Function |
IL1B, TNF | Cytokine signaling |
NFKB1 | Inflammatory transcription |
TLR4 | Damage sensing |
Output: Lowers threshold via synaptic modulation
3.4 Bioenergetic Network
Gene Cluster | Function |
PPARGC1A | Mitochondrial biogenesis |
ATP5F1A | ATP synthesis |
SOD2 | ROS detox |
Output: Maintains neuronal stability
3.5 Plasticity & Network Remodeling
Gene Cluster | Function |
BDNF, CREB1 | Synaptic strengthening |
ARC | Activity-dependent remodeling |
Output: Reinforces epileptogenic circuits
3.6 Epigenetic Control Network
Gene Cluster | Function |
DNMT1, DNMT3A | DNA methylation |
HDAC1, HDAC2 | Chromatin repression |
MECP2 | Gene silencing |
Output: Fixes low-threshold state
IV. MULTI-OMIC INTEGRATION LAYERS
Omics Layer | Network Contribution |
Genomics | Baseline susceptibility |
Transcriptomics | Dynamic gene activation |
Proteomics | Functional receptor expression |
Metabolomics | Energy availability |
Epigenomics | Long-term threshold shifts |
Connectomics | Network synchronization |
V. NETWORK INTERACTION MATRIX
Module | Interacts With | Effect |
Excitatory | Inhibitory | Balance determines ST |
Immune | Excitatory | Amplifies firing |
Metabolic | All | Supports stability |
Epigenetic | All | Locks system state |
VI. THRESHOLD STATES (SCF CLASSIFICATION)
State | ST Value | Description |
Stable | High | No seizure risk |
Primed | Moderate | Vulnerable |
Critical | Low | Pre-ictal |
Collapsed | Zero | Seizure onset |
VII. DYNAMIC THRESHOLD TRAJECTORY
Temporal Progression
Stable
→ Immune activation
→ Excitatory dominance
→ Energy depletion
→ Epigenetic fixation
→ Threshold collapse → Seizure
VIII. NETWORK PERTURBATION ANALYSIS
8.1 High-Risk Perturbations
- ↑ GRIN2B + ↓ GABRA1
- ↑ IL1B + ↑ TNF
- ↓ ATP + ↑ ROS
8.2 Protective Configurations
- ↑ GABA gene expression
- ↑ mitochondrial efficiency
- ↓ inflammatory signaling
IX. SCF MULTI-OMIC PREDICTIVE MODEL
9.1 Input Variables
- Gene expression profiles
- Biomarker panels
- EEG synchronization metrics
9.2 Output
- Seizure probability score
- Time-to-threshold collapse
- Dominant pathogenic pathway
X. PERSONALIZED SCF THRESHOLD PROFILING
Patient Type | Dominant Driver | Strategy |
Genetic | Ion channel genes | Channel modulators |
Traumatic | Inflammation | Anti-inflammatory |
Metabolic | ATP deficiency | Mitochondrial therapy |
Mixed | Multi-system | SCF combination therapy |
XI. THERAPEUTIC NETWORK TARGETING
Network | Intervention |
Excitatory | NMDA antagonists |
Inhibitory | GABA enhancers |
Immune | NF-κB inhibitors |
Metabolic | NAD⁺ boosters |
Epigenetic | HDAC/DNMT modulators |
XII. SCF ADVANCED ANALYTICS
12.1 Network Topology Mapping
- Identify hub genes (SCN1A, GRIN2B, IL1B)
- Target hubs for maximum effect
12.2 Feedback Loop Modeling
- Positive loops: excitatory + inflammation
- Negative loops: inhibitory stabilization
12.3 Digital Twin Simulation
- Simulate threshold changes under therapy
- Predict optimal intervention timing
XIII. NEXT STRATEGIC RESEARCH PATHWAYS
- AI-driven gene network modeling of seizure thresholds
- Real-time integration with wearable EEG + biomarkers
- CRISPR modulation of network hub genes
- Dynamic epigenetic editing to restore threshold
- Closed-loop drug delivery based on threshold prediction
MASTER REGISTRY INDEX
- SCF-MOGN-ST-EPI-GMS-0001 — Multi-Omic Gene Network Threshold Model
- SCF-CT-PTM-EPI-GMS-TRM-0001 — Pseudotime Mapping Atlas
- SCF-MMST-CYTO-EPI-GMS-TRM-0001 — Spatiotemporal Cytogenesis Atlas
- SCF-PGGL-EPI-CORE-0003 — Gene Mapping Atlas
- SCF-MNSMA-EPI-GMS-0001 — Multi-Neurosystems Atlas
- SCF-PATH-EXT-0001 — SCF Pathophysiology Protocol
- SCF-SEF-MD-0001 — Synergistic Evaluation Framework